A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.

Evox voices $45.4m series B
Oxford Sciences Innovation has contributed to a series B round for Evox Therapeutics, a spinout of University of Oxford that has also added GV as a shareholder.

Cambridge scientists devote capital to $129m fund
Eight researchers from Cambridge have raised a $129m patient capital fund that has attracted limited partners including Aviva.

Beier books in Purdue promotion
Brooke Beier has been promoted to vice-president of Purdue’s office of technology…